Krithika Suresh, PhD
Research Assistant Professor, Radiation Oncology
Research Assistant Professor, Biostatistics
[email protected]

Available to mentor

Krithika Suresh, PhD
Research Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    Dr. Suresh is a Research Assistant Professor in the division of Biostatistics and Bioinformatics in the Department of Radiation Oncology. She also has a joint appointment as a Research Assistant Professor of Biostatistics. Her research interests include survival analysis, longitudinal data, joint modeling, and prediction models, with applications in cancer research and other health outcomes.

    Qualifications
    • Masters of Mathematics
      University of Waterloo, Waterloo, 2103
    • PhD, Biostatistics
      University of Michigan, Ann Arbor, 2018
    • Bachelor of Honours Mathematics
      University of Waterloo, Waterloo, 2012
    • Bachelor of Business Administration
      Wilfrid Laurier University, Waterloo, 2012
    Center Memberships
    • Center Member
      Rogel Cancer Center
    Research Overview

    1. Developing prediction models for personalized medicine: I have developed methods that incorporate changing patient information, such as longitudinally collected biomarkers, to produce dynamic risk predictions during a patient’s follow-up.
    2. Statistical analysis of outcomes in cancer research: My work in this area includes identifying important predictors of time-to-event and binary outcomes, propensity-score methods for analyzing observational data, and modelling longitudinal data.
    3. Clinical trial design and analysis: I am the lead biostatistician on several randomized clinical study designs that study community- or clinic-based interventions for a variety of health outcomes.

    Recent Publications See All Publications
    • Presentation
      A Comparison of Natural Histories from Three Microsimulations
      Suresh K. 2024 Nov 22;
    • Presentation
      Patient Reported Outcomes for Predicting Cancer Recurrence
      Suresh K. 2024 Nov 19;
    • Journal Article
      Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collection.
      Edwards DM, Gharzai LA, Wang W, Mayo C, Suresh K, Schipper M, Evans JR, Malloy K, Chinn SB, Prince M, Spector M, Shuman A, Stucken C, Swiecicki PL, Worden F, Jarema J, Henderson C, Kovach A, Brenner C, Shah JL, Mierzwa ML, Casper K. Head Neck, 2024 Nov; 46 (11): 2687 - 2698. DOI:10.1002/hed.27778
      PMID: 38680087
    • Presentation
      Modeling Prostate Cancer: A Microsimulation Study
      Suresh K. 2024 Nov 1;
    • Journal Article
      P18.13.A DE-NOVO PURINE METABOLISM CAN BE TARGETED SAFELY IN GLIOBLASTOMA TREATMENT TO OVERCOME CHEMORADIATION RESISTANCE: AN INTERIM RESULT OF PHASE 0/1 CLINICAL TRIAL
      Umemura Y, Clarke N, Al-Holou W, Elaimy AL, Scott A, Leung D, Kim M, Ferris S, Thomas J, Heth J, Schipper M, Suresh K, Lawrence T, Wahl D. Neuro-Oncology, 2024 Oct 17; 26 (Supplement_5): v98 - v98. DOI:10.1093/neuonc/noae144.329
    • Proceeding / Abstract / Poster
      Imaging Metrics and HPV ctDNA Kinetics in a Phase II Immuno-Chemoradiation Trial for Locoregionally Advanced p16+ Oropharynx Cancer
      Regan SN, Aryal MP, Suresh K, Rosen BS, Walline H, Prince ME, Malloy K, Casper K, Shuman A, Chinn SB, Heft-Neal ME, Swiecicki PL, Worden F, Shah JL, Cao Y, Brenner C, Mierzwa ML. International Journal of Radiation Oncology • Biology • Physics, 2024 Oct; 120 (2): s131 DOI:10.1016/j.ijrobp.2024.07.238
    • Journal Article
      AB036. Targeting glioblastoma de-novo purine metabolism to overcome chemoradiation resistance: an interim result of phase 0/1 clinical trial in newly diagnosed and recurrent glioblastoma.
      Umemura Y, Clarke N, Al-Holou W, Elaimy A, Scott A, Leung D, Kim M, Ferris S, Thomas J, Heth J, Schipper M, Suresh K, Lawrence T, Wahl D. Chin Clin Oncol, 2024 Aug; 13 (Suppl 1): AB036 DOI:10.21037/cco-24-ab036
      PMID: 39295354
    • Journal Article
      Factors in COVID-19 vaccine uptake in five racial/ethnic Colorado communities: A report from the Colorado CEAL project.
      Brewer SE, Bertin KB, Suresh K, LoudHawk-Hedgepeth C, Tamez M, Reno JE, Kwan BM, Nease DE. PLoS One, 2024 19 (6): e0305160 DOI:10.1371/journal.pone.0305160
      PMID: 38865424